Hiki ke huli ʻia ka moʻolelo o Gentolex i ke kauwela o 2013, he hui o nā ʻōpio me ka ʻike i ka ʻoihana e hana i nā manawa e hoʻopili ai i ka honua me nā lawelawe ʻoi aku ka maikaʻi a me nā huahana.
nui
huahana
Nā Huahana Kemika
Nā Huahana Kemika
He wahi kūkulu hale hana holoʻokoʻa o 250,000 square meters ma lalo o ke kūlana honua e hāʻawi i nā hopena maʻalahi, scalable a me ke kumu kūʻai.
ʻO nā mea lāʻau lapaʻau
ʻO nā mea lāʻau lapaʻau
Hāʻawi ʻo Gentolex i kahi ākea o nā API a me nā mea waena no ka noiʻi hoʻomohala ʻana a me ka noi pāʻoihana me ka maʻamau cGMP mai nā hui lōʻihi.Kākoʻo ʻia nā palapala a me nā palapala hōʻoia i nā mea kūʻai aku ma ka honua holoʻokoʻa.
CRO&CDMO
CRO&CDMO
Loaʻa iā mākou ka ʻike waiwai o ka hāʻawi ʻana i nā lawelawe CRO a me CDMO ma ke kaʻina hana hoʻomohala lāʻau peptide no nā papahana IND, NDA & ANDA, hāʻawi i ke alakaʻi palekana a maikaʻi mai ka hoʻomohala ʻana i ka hana ʻoihana.
ʻOihana Kūʻai
ʻOihana Kūʻai
No kēlā mau mea kūʻai aku makemake e pale aku i ka paʻakikī o ka hoʻopili ʻana i nā wahi pili he nui, hāʻawi mākou i nā lawelawe kūʻai maʻamau ʻē aʻe me nā kumu kaulahao lako ʻoi loa.
pili ana
Gentolex
Hiki ke huli ʻia ka moʻolelo o Gentolex i ke kauwela o 2013, he hui o nā ʻōpio me ka ʻike i ka ʻoihana e hana i nā manawa e hoʻopili ai i ka honua me nā lawelawe ʻoi aku ka maikaʻi a me nā huahana.I kēia lā, me nā makahiki o ka hōʻiliʻili ʻana, ua lawelawe ʻo Gentolex Group i nā mea kūʻai mai ʻoi aku ma mua o 15 mau ʻāina ma waena o 5 mau ʻāina, ʻoi aku, ua hoʻokumu ʻia nā hui ʻelele ma Mexico a me ʻApelika Hema, ʻaʻole koke, e hoʻokumu ʻia nā hui ʻelele no nā lawelawe ʻoihana.
nūhou a me ka ʻike
ʻO Acadia Trofinetide Phase III ʻO nā hualoaʻa maikaʻi
Ma 2021-12-06, US manawa, ua hoʻolaha ʻo Acadia Pharmaceuticals (Nasdaq: ACAD) i nā hopena hopena maikaʻi loa o kāna hoʻokolohua lapaʻau Phase III o kāna moho lāʻau, Trofinetide.Hoʻohana nui ʻia ka hoʻāʻo ʻana o ka pae III, i kapa ʻia ʻo Lavender, e loiloi i ka palekana a me ka pono o Trofinetide i ka mālama ʻana o Ret...
ʻO ka holomua noiʻi o nā peptides opioid mai ka ʻae ʻana o Difelikefalin
I ka hoʻomaka ʻana o 2021-08-24, ua hoʻolaha ʻo Cara Therapeutics a me kāna hoa ʻoihana ʻo Vifor Pharma ua ʻae ʻia kāna kappa opioid receptor agonist difelikefalin (KORSUVA™) mua i ka papa no ka mālama ʻana i nā maʻi maʻi maʻi maʻi (CKD). (ka maʻi maʻi haʻahaʻa/koʻikoʻi me ka hemod...
ʻO RhoVac Cancer Peptide Vaccine RV001 e hoʻopaʻa ʻia e ke keʻena waiwai naʻauao Kanada.
Canada manawa 2022-01-24, RhoVac, he pharmaceutical hui e pili ana i ka tumor immunology, hai mai la i kona palapala palapala palapala (No. 2710061) no kona cancer peptide vaccine RV001 e ae ia e ka Canadian Intellectual Property Office (CIPO).Ma mua, ua loaʻa i ka hui nā patent e pili ana ...